You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

https://doi.org/10.1136/jitc-2022-005424corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Vavolizza RD, Petroni GR, Mauldin IS, et al. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). J Immunother Cancer 2022;10:e005424. doi: 10.1136/jitc-2022-005424

    The author Rick Daniel Vavolizza has been updated to Rick D Vavolizza.